Plasma α‐synuclein in patients with Parkinson's disease with and without treatment
- 15 March 2010
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 25 (4) , 489-493
Abstract
Alpha‐synuclein (α‐syn) is an intracellular protein with a high tendency to aggregation. It is the major component of Lewy bodies and may play a key role in the pathogenesis of Parkinson's disease (PD). α‐Syn is also released by neurons and can be detected in biological fluids, such as plasma. The purpose of this study was to determine whether plasma α‐syn concentrations are elevated in newly diagnosed PD patients before treatment (nontreated PD group, ntPD; n = 53) and to compare them with concentrations in PD patients with at least 1 year of specific treatment (tPD; n = 42) and in healthy controls (n = 60). Plasma α‐syn concentrations in the ntPD and tPD groups were similar and significantly higher than in healthy controls. In conclusion, α‐syn was elevated early in the development of PD and specific PD treatment did not change plasma α‐syn levels. © 2010 Movement Disorder SocietyKeywords
Funding Information
- Andalusian Regional Government (CTS 438)
This publication has 23 references indexed in Scilit:
- Neurochemical biomarkers in the differential diagnosis of movement disordersMovement Disorders, 2009
- GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synucleinProceedings of the National Academy of Sciences, 2008
- Red Blood Cells Are the Major Source of Alpha-Synuclein in BloodNeurodegenerative Diseases, 2008
- Determination of α‐synuclein concentration in human plasma using ELISAScandinavian Journal of Clinical and Laboratory Investigation, 2007
- Detection of oligomeric forms of α‐synuclein protein in human plasma as a potential biomarker for Parkinson's diseaseThe FASEB Journal, 2006
- The plasma alpha-synuclein levels in patients with Parkinson’s disease and multiple system atrophyJournal of Neural Transmission, 2006
- Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T MutationThe Journal of Neuroscience, 2004
- α‐Synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasmaThe FASEB Journal, 2003
- Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjectsNeuroscience Letters, 2000
- ParkinsonismNeurology, 1967